News

Article April 19, 2024

A New Therapeutic Target for Traumatic Brain Injury

Research from Gladstone Institutes reveals that a blood coagulation protein is responsible for initiating toxic inflammation and neuron loss after a major head injury. The findings can inform new treatment strategies for a condition that often presents long-term health challenges.

News Release Dementia Traumatic Brain Injury Neurological Disease Akassoglou Lab

Article March 20, 2023

Solving the Aftermath of Brain and Spinal Cord Injuries

Gladstone scientists make headway toward new treatments for people with chronic long-term effects

Gladstone Experts Traumatic Brain Injury Neurological Disease Akassoglou Lab Paz Lab Srivastava Lab Deep Dive

Article July 6, 2022

Pathway Deep in the Brain Makes It Resilient after Injury

Study suggests that targeting a protein in the thalamus could block the long-term damage that follows brain injuries

News Release Research (Publication) Traumatic Brain Injury Neurological Disease Paz Lab

Article March 1, 2022

Gladstone Science Has Three Chances to Win STAT Madness

Gladstone discoveries compete head-to-head with other scientific advancements

Awards COVID-19 Traumatic Brain Injury Alzheimer’s Disease Huang Lab Paz Lab Weinberger Lab Chaturvedi

Gladstone in the News December 15, 2021

Blocking an Immune System Molecule in Mice May Help Prevent Long-Term Disabilities after Traumatic Brain Injury

The Conversation—Individuals who survive traumatic brain injury can suffer from life-long complications, such as cognitive deficits, seizures, and sleep disruption. Jeanne Paz, PhD, describes her work in mice showing that treatment with an antibody that blocks an element of immune system activation may be able to prevent such consequences.

Gladstone Experts Traumatic Brain Injury Neurological Disease Paz Lab

Gladstone in the News December 1, 2021

TBI One Love Podcast

Brain Injury Radio—On a radio show dedicated to traumatic brain injury (TBI), Associate Investigator Jeanne Paz, PhD, explains her life-long interest and current work in TBI and in epilepsy, a common long-term consequence of brain damage.

Gladstone Experts Traumatic Brain Injury Epilepsy Paz Lab

Gladstone in the News November 9, 2021

SF Researchers Find Possible Breakthrough in Treating Traumatic Brain Injuries

ABC News—Traumatic brain injuries can result in sleep disruptions and seizures. Gladstone Associate Investigator Jeanne Paz describes her team’s recent identification of an immune molecule that may be key to these symptoms, and the potential to treat brain injury survivors with new therapies.

Gladstone Experts Traumatic Brain Injury Neurological Disease Paz Lab

Gladstone in the News September 30, 2021

This Molecule Could Be the Key to Understanding Why Concussions Have Such Long-Term Effects

Smithsonian Magazine—Associate Investigator Jeanne Paz, PhD, discusses her lab's recent discovery that C1q, a component of the immune system, mediates cognitive deficits after a traumatic brain injury and may lead to new ways to curb or prevent these deficits.

Gladstone Experts Traumatic Brain Injury Epilepsy Neurological Disease Paz Lab

Article September 9, 2021

Preventing the Long-Term Effects of Traumatic Brain Injury

Study points to a potential new treatment that could prevent chronic complications

News Release Research (Publication) Traumatic Brain Injury Neurological Disease Paz Lab